Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07337109 · ClinicalTrials.gov registry record
A Study Evaluating Oral-Health-Related Quality of Life and Treatment Patterns Among Dentin Hypersensitivity Sufferers
A clinical trial of Dentin Hypersensitivity, sponsored by HALEON.
- Recruiting
- Registry status
- 375
- Enrollment target
- 1
- Study location
NCT07337109: Recruiting study of Dentin Hypersensitivity, sponsored by HALEON.
NCT07337109 is a study of Dentin Hypersensitivity that is actively recruiting participants, run by HALEON. The registered enrollment target is 375 participants, above the 294-participant average among 4 other Dentin Hypersensitivity trials with a reported enrollment target (28% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07337109, a study of Dentin Hypersensitivity, is actively recruiting participants, sponsored by HALEON.
- RECRUITING
- Registry status
- 375 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this study is to characterize changes in Oral-Health-Related Quality of Life (OHrQoL), as measured by the Dentin Hypersensitivity Experience Questionnaire (DHEQ) over a 12-month period.
Primary Outcome
Change from baseline in total DHEQ score and each of the domain scores (daily restrictions, coping behaviors, personal identity, social impact, emotional impact) over 12 months. The DHEQ has total 15 questions each will be scored on a scale ranging from 1 (strongly disagree) to 7 (strongly agree), thus total possible score will be ranging from 15 to 105, where higher score indicates worst outcome.
Conditions Studied
Study Locations (1)
Nevada
- Citruslabs (Virtual Site) - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2025-12-16 |
| Est. Completion | 2027-04 |
What NCT07337109 shows while recruiting
NCT07337109 is an observational study that tracks outcomes without assigning an intervention. The registered 375 participants enrollment target is mid-sized for trials with a published cap, above the 294-participant average among 4 other Dentin Hypersensitivity trials with a reported enrollment target (28% higher).
The record links to 1 condition, with Dentin Hypersensitivity appearing as the primary indexed condition, and to 0 interventions.
NCT07337109 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT07337109 about?
NCT07337109 is a clinical study titled "A Study Evaluating Oral-Health-Related Quality of Life and Treatment Patterns Among Dentin Hypersensitivity Sufferers". The primary purpose of this study is to characterize changes in Oral-Health-Related Quality of Life (OHrQoL), as measured by the Dentin Hypersensitivity Experience Questionnaire (DHEQ) over a 12-month period.
What is the current status of trial NCT07337109?
This trial is currently recruiting. The enrollment target is 375 participants. The study started on 2025-12-16. Estimated completion is 2027-04.
What conditions does trial NCT07337109 study?
This clinical trial studies the following conditions: Dentin Hypersensitivity.
Who is sponsoring clinical trial NCT07337109?
This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07337109 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dentin Hypersensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice
RECRUITING · Phase 3
-
A Study to Investigate the Tooth Whitening and Dentin Hypersensitivity Effectiveness of Two Experimental Toothpastes
RECRUITING · NA
-
A Clinical Study to Assess the Effects of Various Dentifrice Technologies on Dentinal Hypersensitivity
COMPLETED · NA
-
A Comparison Study of Hypersensitivity Treatment
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03686124 · 375 participants · Phase 1
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- NCT04059172 · 375 participants · Early Phase 1
Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management
- NCT04134923 · 375 participants
Imaging Biomarkers in Preclinical and Symptomatic AD
- NCT04569747 · 375 participants · Phase 2
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI